Warning Letter — Bo Wah Enterprises Inc
The FDA issued a Warning Letter to Bo Wah Enterprises Inc. on August 13, 2026, following an evaluation by the Office of Inspections and Investigations.
This notice affects Bo Wah Enterprises Inc. and its internal departments responsible for regulatory compliance, quality management, and facility oversight.
A Warning Letter signifies that the FDA has identified significant violations of regulatory requirements. For the recipient, this typically necessitates a formal written response and corrective actions to avoid further enforcement, such as seizure or injunction. The issuance by the Office of Inspections and Investigations suggests the findings likely stemmed from a site visit or a review of operational records.
Review current compliance status for all active FDA-regulated product lines. Ensure that any prior inspectional observations or agency correspondence have been formally addressed to prevent escalation to Warning Letter status. Verify that facility registration and product listings are current and accurate.
FDA Warning Letter issued to: Bo Wah Enterprises Inc. 08/13/2026 — Office of Inspections and Investigations. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bo-wah-enterprises-inc-736539-08132026
Open in openFDA / FDA.gov